1921
Volume 101, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Immunosuppressive treatments for rheumatic diseases present special problems in areas endemic for chronic infectious diseases because of the possibility of reactivation. Leishmaniasis is a significant neglected tropical disease caused by different species of protozoan parasites within the genus . Amastigotes live as intracellular parasites in a variety of mammalian cells, most notably within phagocytes such as macrophages, and residual parasites can persist even after treatment and healing of the lesions. We herein report a case of relapsing mucosal leishmaniasis after aggressive immunotherapy for ankylosing spondylitis, with requirement for secondary prophylaxis with amphotericin B to prevent reactivation. This approach can be necessary for patients from endemic areas of tegumentary leishmaniasis, who will undergo aggressive immunotherapy.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0066
2019-06-17
2020-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/2/tpmd190066.html?itemId=/content/journals/10.4269/ajtmh.19-0066&mimeType=html&fmt=ahah

References

  1. Kaye P, Scott P, 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9: 604615.
    [Google Scholar]
  2. Conceição-Silva F, Leite-Silva J, Morgado FN, 2018. The binomial parasite-host immunity in the healing process and in reactivation of human tegumentary leishmaniasis. Front Microbiol 9: 1308.
    [Google Scholar]
  3. van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J, 2014. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 20: 286299.
    [Google Scholar]
  4. Tuon FF, Gomes-Silva A, Da-Cruz AM, Duarte MI, Neto VA, Amato VS, 2008. Local immunological factors associated with recurrence of mucosal leishmaniasis. Clin Immunol 128: 442446.
    [Google Scholar]
  5. de Camargo RA, Nicodemo AC, Sumi DV, Gebrim EM, Tuon FF, de Camargo LM, Imamura R, Amato VS, 2014. Facial structure alterations and abnormalities of the paranasal sinuses on multidetector computed tomography scans of patients with treated mucosal leishmaniasis. PLoS Negl Trop Dis 8: e3001.
    [Google Scholar]
  6. Amato VS, Andrade HF, Amato Neto V, Duarte MI, 2003. Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasis. Am J Trop Med Hyg 68: 527528.
    [Google Scholar]
  7. Amato VS, Tuon FF, Camargo RA, Souza RM, Santos CR, Nicodemo AC, 2011. Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis? Am J Trop Med Hyg 85: 818819.
    [Google Scholar]
  8. Murray HW, 2012. Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg 86: 434440.
    [Google Scholar]
  9. Rocio C, Amato VS, Camargo RA, Tuon FF, Nicodemo AC, 2014. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients. Trans R Soc Trop Med Hyg 108: 176178.
    [Google Scholar]
  10. Darcis G, Van der Auwera G, Giot JB, Hayette MP, Tassin F, Arrese Estrada J, Cnops L, Moutschen M, de Leval L, Leonard P, 2017. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infect Dis 17: 478.
    [Google Scholar]
  11. Souza RM, Andrade HF Jr., Duarte MI, Braz LM, Schubach AO, Silva FC, Amato VS, 2017. Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem? Rev Inst Med Trop Sao Paulo 59: e6.
    [Google Scholar]
  12. Mandell MA, Beverley SM, 2017. Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts. Proc Natl Acad Sci U S A Jan 31;114(5).
    [Google Scholar]
  13. Nicodemo AC, Duailibi DF, Feriani D, Duarte MIS, Amato VS, 2017. Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα. PLoS Negl Trop Dis Sep 21;11(9).
    [Google Scholar]
  14. Bogdan C, Röllinghoff M, 1998. The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol 28: 121134.
    [Google Scholar]
  15. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J, 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334359, table of contents.
    [Google Scholar]
  16. Monge-Maillo B, Norman FF, Cruz I, Alvar J, López-Vélez R, 2014. Visceral leishmaniasis and HIV coinfection in the Mediterranean region. PLoS Negl Trop Dis 8: e3021.
    [Google Scholar]
  17. Amato VS, de Andrade HF, Duarte MI, 2003. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop 85: 3949.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0066
Loading
  • Received : 22 Jan 2019
  • Accepted : 06 May 2019
  • Published online : 17 Jun 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error